VREX

18.1050.19%
CA

Christine A. Tsingos

Independent Director

Ms. Christine A. Tsingos is Independent Director of Araceli Biosciences Inc. She was an Independent Director at Telesis Bio, Inc. (formerly known as Codex DNA, Inc.) since May 2021 until August 27, 2024. She has been Independent Director at Envista Holdings Corporation since September 18, 2019 and was an Independent Director of Onto Innovation Inc. (formerly Nanometrics Incorporated) since October 25, 2019 until May 2025. Ms. Tsingos served as Chief Financial Officer and Executive Vice President at Bio-Rad Laboratories, Inc. from December 2002 and 2012 respectively until May 2019 and served as an Executive Officer since April 05, 2019 until May 10, 2019. She served as Vice President at Bio-Rad Laboratories, Inc. since 2003. She served as Chief Operating Officer and Chief Financial Officer at Attest Systems, Inc., from August 2002 to November 2002. Prior to that, she was a Consultant to Attest Systems, Inc. from October 2000 to July 2002. She served as Chief Financial Officer at Tavolo Inc., from November 1999 to September 2000. She was Vice President and Treasurer of Autodesk, Inc., from May 1990 to November 1999. Ms. Tsingos was an Assistant Treasurer of The Cooper Companies, Inc. She has been an Independent Director of Varex Imaging Corporation since 2017. She has public company experience and a proven track record, including being named/Awarded Bay Area Chief Financial Officer of the Year in 2010 and among the Most Influential Women in Business from 2008 to 2012. Ms. Tsingos has expertise in finance, operations and financial reporting matters. She has extensive experience and critical insights in financial management, strategic planning, acquisitions, treasury and investor relations. She earned her Bachelor of Arts in International Studies from the American University in Washington D. C. and an M.B.A in International Business from the George Washington University.

Positions